Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital.
The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead investors in the funding round.
Lux Capital, Two Sigma Ventures, F-Prime, Rsquared, SV Angel, Menlo Ventures, Sequoia Capital, NEA, the Parker Institute for...
